Patent US5694448A successfully refreshed from Google Patents.
Patent EP0336849A1 successfully refreshed from Google Patents.
Patent DE407353C successfully refreshed from Google Patents.
← Back to Patent Explorer
US5489686A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II receptor antagonist properties

Assignee: Warner Lambert Co LLC
•
Filing: 1994-04-28
•
Granted: 1996-02-06
•
Expires: 2014-04-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention relates to novel substituted 1,2,3,4-tetrahydroisoquinolines which are useful in the treatment of vascular restenosis, various disorders of the central nervous system, in the regulation of female reproductive functions, in cognitive enhancement, in atherosclerosis and in treating excessive AVP secretory disorders. Novel intermediates useful in the preparation of the compounds are also disclosed. Methods of using the compounds and pharmaceutical compositions containing them are disclosed.

Inventors

  • 👤 Clifton J. Blankley
  • 👤 John C. Hodges
  • 👤 Sylvester Klutchko

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 14:21
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/96; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/47; A61P; A61P13/00; A61P13/02; A61P15/00; A61P25/00; A61P25/24; A61P25/26; A61P25/28; A61P9/00; A61P9/10; C07C; C07C205/00; C07C205/27; C07C205/35; C07C205/36; C07C205/38; C07C229/00; C07C229/02; C07C229/34; C07C229/36; C07C233/00; C07C233/01; C07C233/45; C07C233/46; C07C233/47; C07C43/00; C07C43/02; C07C43/20; C07C43/225; C07C43/23; C07C45/00; C07C45/61; C07C45/67; C07C45/68; C07C45/70; C07C45/71; C07C47/00; C07C47/52; C07C47/575; C07D217/00; C07D217/22; C07D217/26; C07D233/54; C07D233/66; C07D233/72; C07D233/76; C07D233/78

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 35 words
A compound selected from: 3-Methoxy-2-(phenylmethoxy)phenylalanine 4-Methoxy-3-(phenylmethoxy)phenylalanine 3-Methoxy-2-(2-phenylethoxy)phenylalanine 3-Methoxy-2-(4-nitrophenoxy)phenylalanine 1,2,3,4-Tetrahydro-6-methoxy-5-(phenylmethoxy-3-isoquinolinecarboxylic acid, 1,2,3,4-Tetrahydro-7-methoxy-6-(phenylmethoxy)-3-isoquinolinecarboxylic acid, 1,2,3,4-Tetrahydro-6-methoxy-5-(2-phenylethoxy)-3-isoquinolinecarboxylic acid, 1,2,3,4-Tetrahydro-6-methoxy-5-(4-nitrophenoxy)-3-isoquinolinecarboxylic acid, 1,2,3,4-Tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinolinecarboxylic acid, ethyl ester, 1,2,3,4-Tetrahydro-6-methoxy-5-(4-nitrophenoxy)-3-isoquinolinecarboxylic acid, methyl ester, N-Acetyl-3-methoxy-2-(phenylmethoxy)phenylalanine, 1,2,3,4-Tetrahydro-5-hydroxy-6-methoxy-2-[methyl (phenylamino ) carbonyl]-3-isoquinolinecarboxylic acid, and 2-(Diphenylacetyl)-1,2,3,4-tetrahydro-5-hydroxy-6-methoxy-3-isoquinolinecarboxylic acid, ethyl ester.
Claim 2
Dependent Claim 35 words
A compound selected from: 3-Methoxy-2-(phenylmethoxy)phenylalanine 4-Methoxy-3-(phenylmethoxy)phenylalanine 3-Methoxy-2-(2-phenylethoxy)phenylalanine 3-Methoxy-2-(4-nitrophenoxy)phenylalanine 1,2,3,4-Tetrahydro-6-methoxy-5-(phenylmethoxy-3-isoquinolinecarboxylic acid, 1,2,3,4-Tetrahydro-7-methoxy-6-(phenylmethoxy)-3-isoquinolinecarboxylic acid, 1,2,3,4-Tetrahydro-6-methoxy-5-(2-phenylethoxy)-3-isoquinolinecarboxylic acid, 1,2,3,4-Tetrahydro-6-methoxy-5-(4-nitrophenoxy)-3-isoquinolinecarboxylic acid, 1,2,3,4-Tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinolinecarboxylic acid, ethyl ester, 1,2,3,4-Tetrahydro-6-methoxy-5-(4-nitrophenoxy)-3-isoquinolinecarboxylic acid, methyl ester, N-Acetyl-3-methoxy-2-(phenylmethoxy)phenylalanine, 1,2,3,4-Tetrahydro-5-hydroxy-6-methoxy-2-[methyl (phenylamino ) carbonyl]-3-isoquinolinecarboxylic acid, and 2-(Diphenylacetyl)-1,2,3,4-tetrahydro-5-hydroxy-6-methoxy-3-isoquinolinecarboxylic acid, ethyl ester.

References Cited (Backward Citations)

EP0018104A2 Cited
GB2116542A Cited
EP0049605A1 Cited
GB2095252A Cited
US4812462A Cited
US5236934A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-02-05 1999-08-07 2000-02-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-02-05 2003-08-07 2004-02-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-02-05 2007-08-07 2008-02-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag